NT5E and breast carcinoma: In a mouse model of CD73-expressing AT-3ovadim breast carcinoma, SYN-115 had no single-agent activity but significantly enhanced the antitumor efficacy of the anti-PD-1 mAb RMP1-14 by promoting antitumor T-cell responses [36].